Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials
SONNEVELD, Pieter, GOLDSCHMIDT, Hartmut, DESAI, Avinash, CAKANA, Andrew, LIU, Kevin, VAN DE VELDE, Helgi, ESSELTINE, Dixie-Lee, MOREAU, Philippe, ROSIÑOL, Laura, BLADE, Joan, JOSE LAHUERTA, Juan, CAVO, Michele, TACCHETTI, Paola, ZAMAGNI, Elena, ATTAL, Michel, LOKHORST, Henk M
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma
Laubach, Jacob P., Moslehi, Javid J., Francis, Sanjeev A., San Miguel, Jesús F., Sonneveld, Pieter, Orlowski, Robert Z., Moreau, Philippe, Rosiñol, Laura, Faber, Edward A., Voorhees, Peter, Mateos, Maria‐Victoria, Marquez, Loreta, Feng, Huaibao, Desai, Avinash, Velde, Helgi, Elliott, Jennifer, Shi, Hongliang, Dow, Edward, Jobanputra, Nishith, Esseltine, Dixie‐Lee, Niculescu, Liviu, Anderson, Kenneth C., Lonial, Sagar, Richardson, Paul G.
Published in British journal of haematology (01.08.2017)
Published in British journal of haematology (01.08.2017)
Get full text
Journal Article
Pericardial effusion and cardiac tamponade following percutaneously inserted central line insertion in an extremely low-birth-weight baby: Case report and successful management
Desai, Avinash, Kumar, Abnish, Shanbhag, Praful, Shah, Forum
Published in Indian journal of critical care medicine (01.01.2017)
Published in Indian journal of critical care medicine (01.01.2017)
Get full text
Journal Article
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy
Mateos, María-Victoria, Bringhen, Sara, Richardson, Paul G, Lahuerta, Juan Jose, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, García-Sanz, Ramón, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesús F, Palumbo, Antonio
Published in Haematologica (Roma) (01.06.2014)
Published in Haematologica (Roma) (01.06.2014)
Get full text
Journal Article
S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB‐B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML
Gyurkocza, Boglarka, Seropian, Stuart, Choe, Hannah, Litzow, Mark, Abboud, Camille, Koshy, Nebu, Stiff, Patrick, Tomlinson, Benjamin, Abhyankar, Sunil, Foran, James M, Hari, Parameswaran, Chen, George, Al‐Kadhimi, Zaid, Kebriaei, Partow, Sabloff, Mitchell, Orozco, Johnnie, Jamieson, Katarzyna, Silverman, Margarida, Van Besien, Koen, Schuster, Michael, Law, Arjun, Abedin, Sameem, Larkin, Karilyn, Rowley, Scott, Munshi, Pashna, Cook, Rachel, Mayer, Sebastian, Levy, Moshe Yair, Lazarus, Hillard, Sandmaier, Brenda, Reddy, Vijay, Spross, Jennifer, Mcnamara, Kathleen, Haeuber, Elaina, Vusirikala, Madhuri, Nahar, Akash, Pagel, John, Giralt, Sergio, Desai, Avinash, Nath, Rajneesh
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
A Phase I/IIA Trial of Continuous Five-Day Infusion of Squalamine Lactate (MSI-1256F) Plus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer
HERBST, Roy S, HAMMOND, Lisa A, SOLOMON, Stephen, SCHILLER, Joan H, CARBONE, David P, TRAN, Hai T, HOLROYD, Kenneth J, DESAI, Avinash, WILLIAMS, Jon I, NEBIYOU BEKELE, B, HAIT, Howard, ALLGOOD, Victoria
Published in Clinical cancer research (15.09.2003)
Get full text
Published in Clinical cancer research (15.09.2003)
Journal Article
Analysis of Real‐World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD
Usmani, Saad, Ahmadi, Tahamtan, Ng, Yvette, Lam, Annette, Desai, Avinash, Potluri, Ravi, Mehra, Maneesha
Published in The oncologist (Dayton, Ohio) (01.11.2016)
Published in The oncologist (Dayton, Ohio) (01.11.2016)
Get full text
Journal Article
Sequential salvage chemotherapy and lintuzumab-Ac225 results in deep responses and prolonged survival in adverse risk relapsed/refractory AML and in AML patients that received prior venetoclax therapy
Abedin, Sameem M., Guru Murthy, Guru Subramanian, Desai, Avinash, Chen, Mary, Atallah, Ehab L.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML
Roboz, Gail J., Finn, Laura E., Orozco, Johnnie J., Hegazi, Mohamed, Desai, Avinash, Chen, Mary, Schiller, Gary J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML
Schiller, Gary J., Finn, Laura, Hegazi, Mohamed M., Orozco, Johnnie J., Desai, Avinash, Chen, Mary M, Roboz, Gail J.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
An Ongoing Pilot Study of Targeted Radioimmunotherapy (131-I Apamistamab) Conditioning Prior to CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Geyer, Mark B., Cadzin, Briana, Hosszu, Kinga, Senechal, Brigitte, Spross, Jennifer A., Mark, Alexis, Desai, Avinash, Cathcart, Elizabeth R., Palomba, M. Lia, Pandit-Taskar, Neeta
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features
Abedin, Sameem, Guru Murthy, Guru Subramanian, Szabo, Aniko, Hamadani, Mehdi, Michaelis, Laura C., Carlson, Karen-Sue, Runaas, Lyndsey, Gauger, Katelyn, Desai, Avinash G, Chen, Mary M, Harrington, Alexandra M., Atallah, Ehab L.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article